"10.1371_journal.pone.0063540","plos one","2013-05-15T00:00:00Z","David W Eyre; A Sarah Walker; Jane Freeman; Simon D Baines; Warren N Fawley; Caroline H Chilton; David Griffiths; Alison Vaughan; Derrick W Crook; Tim E A Peto; Mark H Wilcox","NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom; Leeds Institute of Molecular Medicine, University of Leeds, Leeds, West Yorkshire, United Kingdom","Conceived and designed the experiments: DWE ASW DWC TEAP MHW. Performed the experiments: DWE JF SDB WNF CHC DG AV. Analyzed the data: DWE ASW DWC TEAP MHW. Wrote the paper: DWE. Revised the manuscript and approved the final version: DWE ASW JF SDB WNF CHC DG AV DWC TEAP MHW.","The institution of DWC and TEAP received per-case funding from Optimer Pharmaceuticals to support fidaxomicin trial patient expenses. DWC and TEAP also received honoraria from Optimer Pharmaceuticals for participation in additional meetings related to investigative planning for fidaxomicin. MHW has received research support from Actelion, Astellas, Biomerieux, Cubist, Pfizer, Summit and The Medicines Company have funded research in the past 2 years. MHW has received consultancies and/or lecture honoraria in the past 2 years from Actelion, Astellas, Astra-Zeneca, Bayer, Cubist, Durata, J&J, Merck, Nabriva, Novacta, Novartis, Optimer, Pfizer, Sanofi-Pasteur, The Medicines Company, VH Squared, Viropharma. No other author has any conflict of interest. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials.","2013","05","David W Eyre","DWE",11,TRUE,5,7,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
